WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced that Abbott has initiated a voluntary recall for a ...
MANCHESTER, N.H., March 18, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced that Abbott’s FreeStyle Libre 3 ...